Share Price and Basic Stock Data
Last Updated: January 2, 2026, 7:30 am
| PEG Ratio | -4.08 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Jubilant Ingrevia Ltd operates within the agricultural products sector, showcasing a market capitalization of ₹11,237 Cr and a current price per share of ₹706. In the fiscal year ending March 2023, the company reported sales of ₹4,773 Cr, a decline from ₹4,949 Cr in March 2022. The trailing twelve months (TTM) sales stood at ₹4,267 Cr, indicating a slight recovery trend compared to the previous fiscal year. Quarterly sales trends reveal fluctuations, with the most recent quarter (September 2023) reporting ₹1,020 Cr, down from ₹1,075 Cr in June 2023. The sales trajectory demonstrates sensitivity to market conditions and operational efficiency, and the decline in sales from the previous year may raise concerns about demand and competitive pressures in the agricultural sector. Overall, while the company has established a strong revenue base, sustaining growth in the face of market challenges remains a key focus.
Profitability and Efficiency Metrics
Jubilant Ingrevia’s profitability metrics reflect a mixed performance, with a reported net profit of ₹288 Cr for the year ending March 2025, down from ₹308 Cr in March 2023. The operating profit margin (OPM) stood at 12% for the latest fiscal year, an improvement from 11% in the previous year, suggesting effective cost management. However, the return on equity (ROE) was recorded at 8.88%, which is relatively low compared to typical sector averages, indicating potential inefficiencies in capital utilization. The interest coverage ratio (ICR) of 10.01x demonstrates strong ability to cover interest obligations, enhancing financial stability. Additionally, the cash conversion cycle (CCC) of 75 days presents a manageable liquidity position, although it may benefit from further optimization. The company must focus on enhancing its operational efficiencies to improve profit margins and leverage its market position more effectively.
Balance Sheet Strength and Financial Ratios
The balance sheet of Jubilant Ingrevia exhibits a solid foundation, with total assets amounting to ₹5,257 Cr and reserves of ₹3,025 Cr as of September 2025. The company reported total borrowings of ₹806 Cr, reflecting a manageable debt level given its equity capital of ₹16 Cr. The debt-to-equity ratio stands at 0.25, indicating a conservative leverage approach compared to typical industry standards. Key financial ratios such as price-to-book value (P/BV) at 3.51x and return on capital employed (ROCE) at 11.2% signify a healthy return on investments, although the ROCE remains lower than the sector average. The current ratio of 1.32x suggests adequate liquidity to meet short-term obligations. Overall, the balance sheet indicates a stable financial position, but the company must continue to prioritize equity growth and leverage management to enhance overall financial health.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Jubilant Ingrevia shows a diverse ownership structure, with promoters holding 45.22% of the shares as of September 2025, down from 51.47% in previous quarters. This decline may reflect a strategic move to increase public participation or attract institutional investments. Foreign institutional investors (FIIs) accounted for 5.96%, while domestic institutional investors (DIIs) held 23.04%, indicating a significant level of institutional confidence in the company. The public holds 24.94%, suggesting a stable retail investor base. The total number of shareholders stood at 1,25,749, reflecting a gradual increase in retail participation. The shift in shareholding dynamics may impact governance and strategic direction, requiring careful monitoring to ensure alignment with shareholder interests while maintaining operational integrity.
Outlook, Risks, and Final Insight
Jubilant Ingrevia faces an array of strengths and risks that shape its outlook. On one hand, a robust balance sheet, efficient operational metrics, and a diverse shareholder base present a solid foundation for future growth. However, risks such as declining sales figures, low ROE, and potential market volatility in the agricultural sector pose challenges to sustained profitability. The company must navigate these risks by enhancing operational efficiencies, focusing on product innovation, and potentially exploring new markets to bolster revenue streams. Given the current dynamics, the outlook hinges on the company’s ability to adapt to market changes and leverage its strengths effectively. In a favorable scenario, improved sales and operational efficiencies could lead to enhanced profitability, while adverse conditions may necessitate strategic pivots to maintain market competitiveness.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| GRM Overseas Ltd | 2,972 Cr. | 161 | 186/58.6 | 56.1 | 23.5 | 0.00 % | 12.1 % | 14.6 % | 2.00 |
| Freshtrop Fruits Ltd | 120 Cr. | 151 | 179/105 | 165 | 0.00 % | 7.35 % | 8.07 % | 10.0 | |
| City Crops Agro Ltd | 30.7 Cr. | 18.8 | 28.8/17.0 | 15.8 | 0.00 % | 8.46 % | 8.14 % | 10.0 | |
| Chamanlal Setia Exports Ltd | 1,314 Cr. | 264 | 434/242 | 14.0 | 153 | 0.95 % | 16.7 % | 14.2 % | 2.00 |
| Mangalam Global Enterprise Ltd | 460 Cr. | 14.0 | 18.5/11.5 | 17.6 | 6.86 | 0.07 % | 16.8 % | 14.6 % | 1.00 |
| Industry Average | 3,757.40 Cr | 243.76 | 26.91 | 106.69 | 0.33% | 11.80% | 12.33% | 4.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,304 | 1,158 | 1,145 | 1,075 | 1,020 | 966 | 1,074 | 1,024 | 1,045 | 1,057 | 1,051 | 1,038 | 1,121 |
| Expenses | 1,151 | 1,007 | 1,043 | 958 | 902 | 871 | 983 | 915 | 921 | 918 | 905 | 896 | 985 |
| Operating Profit | 153 | 151 | 102 | 117 | 118 | 96 | 91 | 110 | 124 | 138 | 147 | 142 | 135 |
| OPM % | 12% | 13% | 9% | 11% | 12% | 10% | 8% | 11% | 12% | 13% | 14% | 14% | 12% |
| Other Income | 7 | 7 | 9 | 8 | 9 | 9 | 10 | 10 | 10 | 9 | 8 | 11 | 11 |
| Interest | 5 | 7 | 6 | 11 | 13 | 15 | 14 | 14 | 15 | 12 | 14 | 13 | 12 |
| Depreciation | 31 | 30 | 30 | 32 | 34 | 34 | 36 | 39 | 40 | 40 | 39 | 41 | 41 |
| Profit before tax | 124 | 122 | 76 | 81 | 80 | 55 | 51 | 66 | 80 | 96 | 102 | 100 | 93 |
| Tax % | 32% | 25% | 31% | 29% | 28% | 30% | 43% | 26% | 26% | 27% | 27% | 25% | 25% |
| Net Profit | 84 | 92 | 52 | 58 | 57 | 39 | 29 | 49 | 59 | 69 | 74 | 75 | 69 |
| EPS in Rs | 5.29 | 5.75 | 3.28 | 3.62 | 3.61 | 2.42 | 1.84 | 3.06 | 3.70 | 4.36 | 4.65 | 4.71 | 4.36 |
Last Updated: December 30, 2025, 8:33 am
Below is a detailed analysis of the quarterly data for Jubilant Ingrevia Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,121.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,038.00 Cr. (Jun 2025) to 1,121.00 Cr., marking an increase of 83.00 Cr..
- For Expenses, as of Sep 2025, the value is 985.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 896.00 Cr. (Jun 2025) to 985.00 Cr., marking an increase of 89.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 135.00 Cr.. The value appears to be declining and may need further review. It has decreased from 142.00 Cr. (Jun 2025) to 135.00 Cr., marking a decrease of 7.00 Cr..
- For OPM %, as of Sep 2025, the value is 12.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Jun 2025) to 12.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 11.00 Cr..
- For Interest, as of Sep 2025, the value is 12.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.00 Cr. (Jun 2025) to 12.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 41.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 41.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 93.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Jun 2025) to 93.00 Cr., marking a decrease of 7.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 25.00%.
- For Net Profit, as of Sep 2025, the value is 69.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Jun 2025) to 69.00 Cr., marking a decrease of 6.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 4.36. The value appears to be declining and may need further review. It has decreased from 4.71 (Jun 2025) to 4.36, marking a decrease of 0.35.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:07 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 0 | 684 | 4,949 | 4,773 | 4,136 | 4,178 | 4,267 |
| Expenses | 0 | 567 | 4,108 | 4,224 | 3,708 | 3,658 | 3,704 |
| Operating Profit | -0 | 117 | 841 | 549 | 427 | 519 | 562 |
| OPM % | 17% | 17% | 11% | 10% | 12% | 13% | |
| Other Income | 0 | -10 | 22 | 32 | 29 | 38 | 40 |
| Interest | 0 | 7 | 31 | 22 | 53 | 56 | 51 |
| Depreciation | 0 | 22 | 123 | 122 | 136 | 158 | 161 |
| Profit before tax | -0 | 77 | 709 | 437 | 268 | 344 | 390 |
| Tax % | 0% | 30% | 33% | 30% | 32% | 27% | |
| Net Profit | -0 | 54 | 477 | 308 | 183 | 251 | 288 |
| EPS in Rs | -3.40 | 3.41 | 29.93 | 19.31 | 11.48 | 15.77 | 18.08 |
| Dividend Payout % | 0% | 10% | 17% | 26% | 43% | 31% |
YoY Net Profit Growth
| Year | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|
| YoY Net Profit Growth (%) | 783.33% | -35.43% | -40.58% | 37.16% |
| Change in YoY Net Profit Growth (%) | 0.00% | -818.76% | -5.15% | 77.74% |
Jubilant Ingrevia Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 4 years from 2021-2022 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -5% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 331% |
| 3 Years: | -20% |
| TTM: | 59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 16% |
| 1 Year: | -1% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 12% |
| 3 Years: | 9% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 8:35 am
Balance Sheet
Last Updated: December 4, 2025, 1:30 am
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 16 | 16 | 16 | 16 | 16 | 16 |
| Reserves | -0 | 1,907 | 2,417 | 2,650 | 2,722 | 2,911 | 3,025 |
| Borrowings | 0 | 556 | 238 | 407 | 740 | 764 | 806 |
| Other Liabilities | 0 | 888 | 1,111 | 1,176 | 1,241 | 1,324 | 1,410 |
| Total Liabilities | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 5,015 | 5,257 |
| Fixed Assets | 0 | 1,805 | 1,798 | 1,846 | 2,539 | 2,581 | 2,611 |
| CWIP | 0 | 65 | 174 | 525 | 331 | 525 | 633 |
| Investments | 0 | 50 | 6 | 8 | 15 | 37 | 26 |
| Other Assets | 0 | 1,446 | 1,804 | 1,870 | 1,834 | 1,872 | 1,985 |
| Total Assets | 0 | 3,366 | 3,782 | 4,249 | 4,719 | 5,015 | 5,257 |
Below is a detailed analysis of the balance sheet data for Jubilant Ingrevia Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 3,025.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,911.00 Cr. (Mar 2025) to 3,025.00 Cr., marking an increase of 114.00 Cr..
- For Borrowings, as of Sep 2025, the value is 806.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 764.00 Cr. (Mar 2025) to 806.00 Cr., marking an increase of 42.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 1,410.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,324.00 Cr. (Mar 2025) to 1,410.00 Cr., marking an increase of 86.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 5,257.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 5,015.00 Cr. (Mar 2025) to 5,257.00 Cr., marking an increase of 242.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 2,611.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,581.00 Cr. (Mar 2025) to 2,611.00 Cr., marking an increase of 30.00 Cr..
- For CWIP, as of Sep 2025, the value is 633.00 Cr.. The value appears strong and on an upward trend. It has increased from 525.00 Cr. (Mar 2025) to 633.00 Cr., marking an increase of 108.00 Cr..
- For Investments, as of Sep 2025, the value is 26.00 Cr.. The value appears to be declining and may need further review. It has decreased from 37.00 Cr. (Mar 2025) to 26.00 Cr., marking a decrease of 11.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,985.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,872.00 Cr. (Mar 2025) to 1,985.00 Cr., marking an increase of 113.00 Cr..
- For Total Assets, as of Sep 2025, the value is 5,257.00 Cr.. The value appears strong and on an upward trend. It has increased from 5,015.00 Cr. (Mar 2025) to 5,257.00 Cr., marking an increase of 242.00 Cr..
Notably, the Reserves (3,025.00 Cr.) exceed the Borrowings (806.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | -439.00 | 603.00 | 142.00 | -313.00 | -245.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 251 | 43 | 39 | 50 | 53 | |
| Inventory Days | 601 | 117 | 146 | 160 | 163 | |
| Days Payable | 685 | 103 | 113 | 131 | 141 | |
| Cash Conversion Cycle | 167 | 57 | 72 | 80 | 75 | |
| Working Capital Days | 220 | 49 | 42 | 37 | 29 | |
| ROCE % | 8% | 29% | 16% | 10% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| DSP Small Cap Fund | 7,000,000 | 2.91 | 495.64 | 5,188,657 | 2025-12-08 03:47:31 | 34.91% |
| DSP Mid Cap Fund | 4,469,774 | 1.59 | 316.48 | 3,926,722 | 2025-12-08 03:47:31 | 13.83% |
| Kotak Small Cap Fund | 3,629,417 | 1.47 | 256.98 | N/A | N/A | N/A |
| Axis Small Cap Fund | 2,578,209 | 0.68 | 182.55 | N/A | N/A | N/A |
| Franklin India Small Cap Fund | 1,600,000 | 0.84 | 113.29 | N/A | N/A | N/A |
| Edelweiss Small Cap Fund | 1,424,301 | 1.89 | 100.85 | N/A | N/A | N/A |
| Bandhan Small Cap Fund | 1,391,916 | 0.54 | 98.55 | N/A | N/A | N/A |
| UTI Small Cap Fund | 1,169,215 | 1.71 | 82.79 | 1,106,633 | 2025-12-15 03:12:17 | 5.66% |
| DSP Large Cap Fund | 1,146,659 | 1.13 | 81.19 | N/A | N/A | N/A |
| HDFC Value Fund | 925,556 | 0.85 | 65.53 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 15.89 | 11.56 | 19.34 | 29.98 | 20.78 |
| Diluted EPS (Rs.) | 15.84 | 11.55 | 19.34 | 29.97 | 20.78 |
| Cash EPS (Rs.) | 25.85 | 20.19 | 27.03 | 37.75 | 4.80 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 185.11 | 173.27 | 167.72 | 153.06 | 120.73 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 185.11 | 173.27 | 167.72 | 153.06 | 120.73 |
| Revenue From Operations / Share (Rs.) | 264.19 | 261.78 | 300.23 | 311.34 | 42.95 |
| PBDIT / Share (Rs.) | 35.22 | 28.89 | 36.52 | 54.31 | 7.52 |
| PBIT / Share (Rs.) | 25.25 | 20.27 | 28.83 | 46.55 | 6.13 |
| PBT / Share (Rs.) | 21.73 | 16.94 | 27.47 | 44.60 | 4.86 |
| Net Profit / Share (Rs.) | 15.89 | 11.57 | 19.35 | 29.99 | 3.41 |
| NP After MI And SOA / Share (Rs.) | 15.88 | 11.58 | 19.34 | 29.99 | 3.41 |
| PBDIT Margin (%) | 13.33 | 11.03 | 12.16 | 17.44 | 17.50 |
| PBIT Margin (%) | 9.55 | 7.74 | 9.60 | 14.95 | 14.27 |
| PBT Margin (%) | 8.22 | 6.47 | 9.15 | 14.32 | 11.31 |
| Net Profit Margin (%) | 6.01 | 4.42 | 6.44 | 9.63 | 7.94 |
| NP After MI And SOA Margin (%) | 6.01 | 4.42 | 6.44 | 9.63 | 7.94 |
| Return on Networth / Equity (%) | 8.58 | 6.68 | 11.53 | 19.59 | 2.82 |
| Return on Capital Employeed (%) | 10.99 | 9.29 | 14.88 | 26.96 | 3.93 |
| Return On Assets (%) | 4.99 | 3.86 | 7.22 | 12.55 | 1.60 |
| Long Term Debt / Equity (X) | 0.12 | 0.15 | 0.05 | 0.04 | 0.23 |
| Total Debt / Equity (X) | 0.25 | 0.26 | 0.14 | 0.09 | 0.23 |
| Asset Turnover Ratio (%) | 0.85 | 0.92 | 1.16 | 1.38 | 0.41 |
| Current Ratio (X) | 1.32 | 1.38 | 1.54 | 1.68 | 1.59 |
| Quick Ratio (X) | 0.64 | 0.65 | 0.66 | 0.81 | 0.91 |
| Inventory Turnover Ratio (X) | 4.43 | 4.19 | 2.84 | 4.08 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 31.80 | 43.18 | 25.84 | 9.52 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 19.54 | 24.75 | 18.49 | 7.56 | 0.00 |
| Earning Retention Ratio (%) | 68.20 | 56.82 | 74.16 | 90.48 | 0.00 |
| Cash Earning Retention Ratio (%) | 80.46 | 75.25 | 81.51 | 92.44 | 0.00 |
| Interest Coverage Ratio (X) | 10.01 | 8.67 | 26.90 | 27.91 | 16.34 |
| Interest Coverage Ratio (Post Tax) (X) | 5.52 | 4.47 | 15.25 | 16.41 | 10.18 |
| Enterprise Value (Cr.) | 10933.88 | 7789.81 | 6031.88 | 7331.49 | 4498.03 |
| EV / Net Operating Revenue (X) | 2.62 | 1.88 | 1.26 | 1.48 | 6.57 |
| EV / EBITDA (X) | 19.63 | 17.07 | 10.39 | 8.49 | 37.57 |
| MarketCap / Net Operating Revenue (X) | 2.46 | 1.73 | 1.20 | 1.44 | 6.08 |
| Retention Ratios (%) | 68.19 | 56.81 | 74.15 | 90.47 | 0.00 |
| Price / BV (X) | 3.51 | 2.61 | 2.15 | 2.94 | 2.16 |
| Price / Net Operating Revenue (X) | 2.46 | 1.73 | 1.20 | 1.44 | 6.08 |
| EarningsYield | 0.02 | 0.02 | 0.05 | 0.06 | 0.01 |
After reviewing the key financial ratios for Jubilant Ingrevia Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 15.89. This value is within the healthy range. It has increased from 11.56 (Mar 24) to 15.89, marking an increase of 4.33.
- For Diluted EPS (Rs.), as of Mar 25, the value is 15.84. This value is within the healthy range. It has increased from 11.55 (Mar 24) to 15.84, marking an increase of 4.29.
- For Cash EPS (Rs.), as of Mar 25, the value is 25.85. This value is within the healthy range. It has increased from 20.19 (Mar 24) to 25.85, marking an increase of 5.66.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.11. It has increased from 173.27 (Mar 24) to 185.11, marking an increase of 11.84.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 185.11. It has increased from 173.27 (Mar 24) to 185.11, marking an increase of 11.84.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 264.19. It has increased from 261.78 (Mar 24) to 264.19, marking an increase of 2.41.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 35.22. This value is within the healthy range. It has increased from 28.89 (Mar 24) to 35.22, marking an increase of 6.33.
- For PBIT / Share (Rs.), as of Mar 25, the value is 25.25. This value is within the healthy range. It has increased from 20.27 (Mar 24) to 25.25, marking an increase of 4.98.
- For PBT / Share (Rs.), as of Mar 25, the value is 21.73. This value is within the healthy range. It has increased from 16.94 (Mar 24) to 21.73, marking an increase of 4.79.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 15.89. This value is within the healthy range. It has increased from 11.57 (Mar 24) to 15.89, marking an increase of 4.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 15.88. This value is within the healthy range. It has increased from 11.58 (Mar 24) to 15.88, marking an increase of 4.30.
- For PBDIT Margin (%), as of Mar 25, the value is 13.33. This value is within the healthy range. It has increased from 11.03 (Mar 24) to 13.33, marking an increase of 2.30.
- For PBIT Margin (%), as of Mar 25, the value is 9.55. This value is below the healthy minimum of 10. It has increased from 7.74 (Mar 24) to 9.55, marking an increase of 1.81.
- For PBT Margin (%), as of Mar 25, the value is 8.22. This value is below the healthy minimum of 10. It has increased from 6.47 (Mar 24) to 8.22, marking an increase of 1.75.
- For Net Profit Margin (%), as of Mar 25, the value is 6.01. This value is within the healthy range. It has increased from 4.42 (Mar 24) to 6.01, marking an increase of 1.59.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.01. This value is below the healthy minimum of 8. It has increased from 4.42 (Mar 24) to 6.01, marking an increase of 1.59.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 15. It has increased from 6.68 (Mar 24) to 8.58, marking an increase of 1.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.99. This value is within the healthy range. It has increased from 9.29 (Mar 24) to 10.99, marking an increase of 1.70.
- For Return On Assets (%), as of Mar 25, the value is 4.99. This value is below the healthy minimum of 5. It has increased from 3.86 (Mar 24) to 4.99, marking an increase of 1.13.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has decreased from 0.15 (Mar 24) to 0.12, marking a decrease of 0.03.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.25. This value is within the healthy range. It has decreased from 0.26 (Mar 24) to 0.25, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.85. It has decreased from 0.92 (Mar 24) to 0.85, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.32. This value is below the healthy minimum of 1.5. It has decreased from 1.38 (Mar 24) to 1.32, marking a decrease of 0.06.
- For Quick Ratio (X), as of Mar 25, the value is 0.64. This value is below the healthy minimum of 1. It has decreased from 0.65 (Mar 24) to 0.64, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.43. This value is within the healthy range. It has increased from 4.19 (Mar 24) to 4.43, marking an increase of 0.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 31.80. This value is within the healthy range. It has decreased from 43.18 (Mar 24) to 31.80, marking a decrease of 11.38.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 19.54. This value is below the healthy minimum of 20. It has decreased from 24.75 (Mar 24) to 19.54, marking a decrease of 5.21.
- For Earning Retention Ratio (%), as of Mar 25, the value is 68.20. This value is within the healthy range. It has increased from 56.82 (Mar 24) to 68.20, marking an increase of 11.38.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 80.46. This value exceeds the healthy maximum of 70. It has increased from 75.25 (Mar 24) to 80.46, marking an increase of 5.21.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 10.01. This value is within the healthy range. It has increased from 8.67 (Mar 24) to 10.01, marking an increase of 1.34.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.52. This value is within the healthy range. It has increased from 4.47 (Mar 24) to 5.52, marking an increase of 1.05.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,933.88. It has increased from 7,789.81 (Mar 24) to 10,933.88, marking an increase of 3,144.07.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.62. This value is within the healthy range. It has increased from 1.88 (Mar 24) to 2.62, marking an increase of 0.74.
- For EV / EBITDA (X), as of Mar 25, the value is 19.63. This value exceeds the healthy maximum of 15. It has increased from 17.07 (Mar 24) to 19.63, marking an increase of 2.56.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.46. This value is within the healthy range. It has increased from 1.73 (Mar 24) to 2.46, marking an increase of 0.73.
- For Retention Ratios (%), as of Mar 25, the value is 68.19. This value is within the healthy range. It has increased from 56.81 (Mar 24) to 68.19, marking an increase of 11.38.
- For Price / BV (X), as of Mar 25, the value is 3.51. This value exceeds the healthy maximum of 3. It has increased from 2.61 (Mar 24) to 3.51, marking an increase of 0.90.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.46. This value is within the healthy range. It has increased from 1.73 (Mar 24) to 2.46, marking an increase of 0.73.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Jubilant Ingrevia Ltd:
- Net Profit Margin: 6.01%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.99% (Industry Average ROCE: 11.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.58% (Industry Average ROE: 12.33%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.52
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 39.1 (Industry average Stock P/E: 26.91)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.01%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Agricultural Products | Bhartiagram, Amroha District Uttar Pradesh 244223 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shyam S Bhartia | Chairman |
| Mr. Hari S Bhartia | Co-Chairman & WholeTime Director |
| Mr. Deepak Jain | Managing Director & CEO |
| Mr. Priyavrat Bhartia | Director |
| Mr. Aashti Bhartia | Director |
| Mr. Vijay Kumar Srivastava | Whole Time Director |
| Mr. Sushil Kumar Roongta | Independent Director |
| Mr. Arun Seth | Independent Director |
| Mr. Pradeep Banerjee | Independent Director |
| Mr. Siraj Azmat Chaudhry | Independent Director |
| Ms. Ameeta Chatterjee | Independent Director |
| Ms. Sudha Pillai | Independent Director |
FAQ
What is the intrinsic value of Jubilant Ingrevia Ltd?
Jubilant Ingrevia Ltd's intrinsic value (as of 02 January 2026) is ₹534.30 which is 24.43% lower the current market price of ₹707.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹11,261 Cr. market cap, FY2025-2026 high/low of ₹885/535, reserves of ₹3,025 Cr, and liabilities of ₹5,257 Cr.
What is the Market Cap of Jubilant Ingrevia Ltd?
The Market Cap of Jubilant Ingrevia Ltd is 11,261 Cr..
What is the current Stock Price of Jubilant Ingrevia Ltd as on 02 January 2026?
The current stock price of Jubilant Ingrevia Ltd as on 02 January 2026 is ₹707.
What is the High / Low of Jubilant Ingrevia Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Jubilant Ingrevia Ltd stocks is ₹885/535.
What is the Stock P/E of Jubilant Ingrevia Ltd?
The Stock P/E of Jubilant Ingrevia Ltd is 39.1.
What is the Book Value of Jubilant Ingrevia Ltd?
The Book Value of Jubilant Ingrevia Ltd is 191.
What is the Dividend Yield of Jubilant Ingrevia Ltd?
The Dividend Yield of Jubilant Ingrevia Ltd is 0.71 %.
What is the ROCE of Jubilant Ingrevia Ltd?
The ROCE of Jubilant Ingrevia Ltd is 11.2 %.
What is the ROE of Jubilant Ingrevia Ltd?
The ROE of Jubilant Ingrevia Ltd is 8.88 %.
What is the Face Value of Jubilant Ingrevia Ltd?
The Face Value of Jubilant Ingrevia Ltd is 1.00.